Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026

Same author

Long-term Outcomes After Resection of Solitary Colorectal Liver Metastases.

Annals of surgical oncology·2026

Same author

ASO Visual Abstract: Long-Term Outcomes After Resection of Solitary Colorectal Liver Metastases.

Annals of surgical oncology·2026

Same author

Pancreas Cancer Risk During Intraductal Papillary Mucinous Neoplasm Surveillance - A SEER-Based Comparison.

Annals of surgery·2026

Same author

ASO Visual Abstract: The Margin of the Largest Tumor Predicts Overall Survival After Resection of Multi-tumor Colorectal Liver Metastases.

Annals of surgical oncology·2026

Same author

ASO Visual Abstract: Eligibility for Liver Transplantation in Patients with Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026

Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026

Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 30, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

mRNA Vaccines for Cancer Treatment.

Robert J Torphy¹, Vinod Balachandran², Kevin C Soares³

¹Department of Surgery, University of North Carolina School of Medicine, 4001 Burnett-Womack Building, CB #7050, Chapel Hill, NC 27599, USA.

Surgical Oncology Clinics of North America

|March 28, 2026

Summary

This summary is machine-generated.

Messenger RNA (mRNA) cancer vaccines provide a flexible platform for personalized immunotherapy. Future research should explore combination treatments and adaptive trial designs to improve cancer treatment accessibility.

Keywords:

Cancer Immunotherapy Personalized vaccine Vaccine mRNA

More Related Videos

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Published on: August 28, 2013

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Mar 30, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Published on: August 28, 2013

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

Area of Science:

Oncology
Immunology
Biotechnology

Background:

Messenger RNA (mRNA) cancer vaccines represent a significant advancement in personalized immunotherapy.
They enable the targeted delivery of tumor antigens to elicit a robust immune response against cancer.

Purpose of the Study:

To review the fundamental principles of mRNA vaccine design.
To summarize emerging clinical trial data for mRNA cancer vaccines in solid tumors.
To identify current limitations and future directions for mRNA cancer vaccine development.

Main Methods:

Literature review of mRNA vaccine design principles.
Analysis of published clinical trial data for solid tumors.
Discussion of limitations and future research strategies.

Main Results:

mRNA vaccines are a versatile platform for personalized cancer immunotherapy.
Early clinical data show promise across various solid tumors.
Key challenges include optimizing immune response and patient selection.

Conclusions:

mRNA cancer vaccines hold significant potential for cancer treatment.
Future clinical trials should focus on combination therapies and adaptive designs.
Optimizing patient selection and accelerating clinical translation are crucial for broader access.